Rights and permissions
About this article
Cite this article
Allogeneic PBSCT cost saving in haematological malignancy. Pharmacoecon. Outcomes News 236, 9 (1999). https://doi.org/10.1007/BF03275243
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275243